EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against eHealth, Inc. - EHTH

The Rosen Law Firm announces that it is investigating potential securities claims on behalf of shareholders of eHealth, Inc. (NASDAQ:EHTH) resulting from allegations eHealth may have issued materially misleading business information to the investing public.

On January 14, 2015, eHealth announced disappointing preliminary results for the quarter ended December 31, 2014 and indicated that it will report lower than expected results for the quarter. eHealth expects to report a loss of $0.56 per share to $0.47 per share for the quarter – well below analysts’ expectations of $0.11 per share. eHealth also expects revenue of $43 million to $45 million for the quarter in comparison to analysts' estimates of $52.6 million. On this news, shares of eHealth fell $11.38 per share or over 54% to close at $9.42 per share on January 15, 2015, damaging investors.

The Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by eHealth investors. If you purchased eHealth stock on or before January 14, 2015, please visit the website at http://rosenlegal.com/cases-479.html for more information. You may also contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contacts:

Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.